Chronic Kidney Disease-Mineral and Bone Disorder
11
4
6
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
Mineral Bone Disorder in Dialysis
DePTH: De-emphasize PTH
PRevEnting FracturEs in REnal Disease - 1
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
Chinese CKD-MBD Prevalence Survey (CRISS-MBD)
Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients
Improving Phosphate Control in Children With CKD
Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
Relationship Between Serum 1,25-dihydroxy Vitamin D and Markers of Bone Metabolism in Renal Dysfunction Patients
Integrated Diagnosis and Treatment of CKD on Outcomes
To Investigate the Bone and Muscle Abnormalities in Patients With Chronic Kidney Disease With MRI